(Press-News.org) Dietary guidelines should emphasise the role played by added sugars, particularly fructose, in the fight to curb the prevalence of cardiovascular, they insist.
Cardiovascular disease is the number one cause of premature death in the developed world. And high blood pressure is its most important risk factor,accounting for almost 350,000 deaths in the US in 2009 and costing more than $50 billion US dollars every year.
Dietary approaches to lower high blood pressure have historically focused on cutting salt intake. But the potential benefits of this approach "are debatable," say the authors.
This is because the average reductions in blood pressure achieved by restricting salt intake tend to be relatively small, and there is some evidence to suggest that 3-6 g salt daily may be optimal for health, and that intake below 3 g may actually be harmful, they write.
Most salt in the diet comes from processed foods, which also happen to be a rich source of added sugars, they point out.
"Sugar may be much more meaningfully related to blood pressure than sodium, as suggested by a greater magnitude of effect with dietary manipulation," they state.
"Compelling evidence from basic science, population studies, and clinical trials implicates sugars, and particularly the monosaccharide fructose, as playing a major role in the development of hypertension [high blood pressure]," they write.
"Moreover, evidence suggests that sugars in general, and fructose in particular, may contribute to overall cardiovascular risk through a variety of mechanisms," they add.
They point the finger in particular to high fructose corn syrup, which is the most frequently used sweetener in processed foods, particularly fruit-flavoured and fizzy drinks.
"Worldwide, sugar sweetened beverage consumption has been implicated in 180,000 deaths a year," they write. Around 300 years ago, people only consumed a few pounds of sugar a year, they add, whereas current estimates suggest that average consumption in the US is 77-152 pounds a year--equivalent to 24-47 teaspoons a day.
The evidence suggests that people whose dietary intake of added sugars adds up to at least a quarter of their total daily calories have almost triple the cardiovascular disease risk of those who consume less than 10%.
And a daily intake of more than 74 g of fructose is associated with a 30% greater risk of blood pressure above 140/90 mm Hg and a 77% increased risk of blood pressure above 160/100 mm Hg.
A high fructose diet has also been linked to an unfavourable blood fat profile, higher fasting blood insulin levels, and a doubling in the risk of metabolic syndrome.
Some dietary guidelines do include recommendations about daily intake of added sugars, but are not stringent enough, nor do they make specific recommendations about fructose, say the authors. And it's high time they did.
Of particular concern, they say, is that UK and US teens may be consuming added sugars up to 16 times the recommended limit.
They emphasise that naturally-occurring sugars found in fruit and vegetables are not harmful to health. Eating fruit and vegetables is almost certainly beneficial.
"Just as most dietary sodium does not come from the salt shaker, most dietary sugar does not come from the sugar bowl; reducing consumption of added sugars by limiting processed foods containing it, made by corporations, would be a good place to start," write the authors.
And they go on to warn: "The evidence is clear that even moderate doses of added sugar for short durations may cause substantial harm."
INFORMATION:
Those with the largest waists and hips combined are twice as likely to be affected as those with measurements in the normal range, the findings indicate.
Sudden cardiac death, or SCD for short, occurs without warning, and is caused by a sudden unexpected loss of heart function, which rapidly reduces blood flow around the body, including to the brain. It is distinct from a heart attack, and kills around 300,000 people in the USA every year.
Obesity has long been associated with various unfavourable changes in cardiovascular health, including SCD. But the researchers ...
SAN ANTONIO, TX, USA and Neu-Isenburg/Frankfurt, Germany -- December 10, 2014 -- The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based paclitaxel. The findings are from the GeparSepto clinical trial sponsored by GBG and conducted together with the German AGO-B study group involving over 1200 patients, which is the largest randomized Phase III study ever completed with nab-paclitaxel and the first one completed in high risk early breast ...
Scientists have developed an ingredient that can be added to foods to make them more filling.
In its first tests in humans, researchers at Imperial College London and the University of Glasgow found that the ingredient is effective at preventing weight gain in overweight volunteers.
The ingredient contains propionate, which stimulates the gut to release hormones that act on the brain to reduce hunger. Propionate is produced naturally when dietary fibre is fermented by microbes in the gut, but the new ingredient, called inulin-propionate ester (IPE), provides much larger ...
PROVIDENCE, R.I. [Brown University] -- A study of more than 12 million acute care hospitalizations over a five-year span found that as quality improved on each of 17 measures so did racial and ethnic equity. Nine major disparities evident in 2005 had mostly or totally disappeared by the end of 2010.
The study, led by Dr. Amal Trivedi of Brown University and published in the New England Journal of Medicine, found that care for blacks and Hispanics became better and more equitable when comparing hospitals principally serving whites to hospitals principally serving minorities, ...
Despite recent significant gains in health care access throughout the nation, people of color continue to grapple with a disproportionate burden of chronic disease. Two studies in the current issue of the New England Journal of Medicine (NEJM) indicate that differences in how care is delivered to patients in various racial or ethnic groups have narrowed nationally, but health outcomes remain worse for blacks than for whites.
In his editorial "How to Achieve Health Equity," also published in the just released NEJM, Marshall Chin, MD, MPH, the Richard Parrillo Family Professor ...
WASHINGTON -- A five-minute functional MRI (fMRI) test can pick up neuronal dysfunction in HIV-positive individuals who don't yet exhibit cognitive decline, say neuroscientists and clinicians at Georgetown University Medical Center.
Their study in Neuroimaging: Clinical provides proof-of-concept that imaging can help track neural functioning in this population, known to be affected by the virus and potentially by the treatments meant to keep HIV at bay.
The issue of neural dysfunction in the HIV-positive population is significant, says Georgetown neuroscientist Xiong ...
ANN ARBOR, Mich. -- Despite years of effort to help American seniors with high blood pressure, heart disease, or diabetes get their blood pressure, cholesterol and blood sugar under control, new research shows wide gaps between older people of different ethnic backgrounds in all three of these key health measures.
Black seniors in Medicare Advantage health plans are still much less likely than their white peers to have each of the three measures in check, according to a new study published in the December 11 issue of the New England Journal of Medicine.
If not well ...
Treatment of acute traumatic brain injury with the hormone progesterone provides no significant benefit to patients when compared with placebo, a NIH-funded phase III clinical trial has concluded.
The results are scheduled for publication Dec. 10 in the New England Journal of Medicine.
The study, named ProTECT III, involved 49 trauma centers across the United States between July 2009 and November 2013. The study was originally planned to include 1,140 patients, but was stopped after 882 patients because safety monitors determined that additional enrollment would be ...
A study concluded that after five days of treatment with a novel formulation of progesterone acutely administered to patients with severe traumatic brain injury (TBI), showed no clinical benefits.
The paper entitled, "A Clinical Trial of Progesterone for Severe Traumatic Brain Injury," will be published online in The New England Journal of Medicine, December 10, 2014.
This trial, referred to as SyNAPSe, reports on a large prospective randomized clinical trial that investigated the effects of progesterone administered to severe TBI patients," said Raj K. Narayan, ...
A new study out today in the journal Neurology shows that pregabalin is not effective in controlling the pain associated with lumbar spinal stenosis, the most common type of chronic lower back pain in older adults.
"Chronic low back pain is one of the most common reasons why older adults go to the doctor and lumbar stenosis is the leading indication for surgery in this age group," said John Markman, M.D., director of the Translational Pain Research Program in the University of Rochester Department of Neurosurgery and lead author of the study. "While physicians have ...
